We found that PGM5-AS1 was significantly decreased in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) compared with normal tissues with a fold-change of 0.24 and 0.09 in LUAD and LUSC, respectively (Fig. 1A). Here, PGM5 is linked to lung adenocarcinoma.